China Pharma Inc.

AMEX: CPHI · Real-Time Price · USD
1.46
0.00 (0.00%)
At close: Aug 15, 2025, 9:41 AM

China Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
626.88K 1.42M 2.03M 4.86M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
281.07K 728.31K 464.45K 835.4K
Inventory
2.27M 3.73M 2.95M 3.34M
Other Current Assets
n/a n/a 444.64K 471.00
Total Current Assets
3.27M 6M 5.96M 9.09M
Property-Plant & Equipment
4.53M 6.82M 9.61M 12.97M
Goodwill & Intangibles
7.09M 3.65M 2.21M 589.62K
Total Long-Term Assets
11.62M 10.47M 11.82M 13.56M
Total Assets
14.89M 16.47M 17.78M 22.65M
Account Payables
225.11K 966.42K 667.08K 926.75K
Deferred Revenue
162.21K 90.51K 520.29K 210.03K
Short-Term Debt
2.16M 3.1M 8.72M 7.11M
Other Current Liabilities
1.59M 1.26M 372.58K 327.03K
Total Current Liabilities
5.02M 6.82M 12.74M 10.51M
Long-Term Debt
1.39M 1.41M n/a 5.25M
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
2.12M 2.19M 754.7K 6.12M
Total Liabilities
7.14M 9.01M 13.49M 16.63M
Total Debt
3.59M 4.63M 8.76M 12.49M
Common Stock
32.62K 10.63K 74.91K 47.34K
Retained Earnings
-44.03M -39.29M -36.21M -32.24M
Comprehensive Income
11.32M 11.45M 11.57M 12.56M
Shareholders Equity
7.75M 7.45M 4.29M 6.02M
Total Investments
n/a n/a n/a n/a